Takeda Pharmaceutical Co., Ltd. (TAK)
18.46
+0.09
(+0.49%)
USD |
NYSE |
Feb 13, 16:00
18.55
+0.09
(+0.49%)
After-Hours: 20:00
Takeda Pharmaceutical Total Liabilities (Quarterly) : 49.54B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 1.717B |
| Protagonist Therapeutics, Inc. | 56.25M |
| Nxera Pharma Co., Ltd. | 470.76M |
| PeptiDream Inc. | 169.13M |
| Stemcell Holdings, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.30B |
| Shareholders Equity (Quarterly) | 48.76B |
| Debt to Equity Ratio | 0.635 |
| Current Ratio | 1.194 |
| Net Debt Paydown Yield | 1.77% |